Amalgamated Bank Fibrogen Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.73 - $2.73 $3,551 - $13,281	-4,865 Reduced 61.92%	2,992 $7,000
Q4 2023 Feb 06, 2024	SELL	$0.38 - $0.91 $338 - $810	-891 Reduced 10.19%	7,857 $7,000
Q2 2023 Aug 11, 2023	SELL	$2.49 - $20.59 $8,207 - $67,864	-3,296 Reduced 27.37%	8,748 $23,000
Q1 2023 May 02, 2023	SELL	$15.95 - $25.18 $25,360 - $40,036	-1,590 Reduced 11.66%	12,044 $225,000
Q3 2022 Nov 09, 2022	BUY	$11.4 - $14.6 $2,257 - $2,890	198 Added 1.47%	13,634 $177,000
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $2,318 - $3,784	-292 Reduced 2.13%	13,436 $142,000
Q1 2022 Jun 30, 2022	SELL	$12.02 - $16.79 $13,618 - $19,023	-1,133 Reduced 7.62%	13,728 $165,000
Q4 2021 Feb 15, 2022	SELL	$9.93 - $15.39 $2,770 - $4,293	-279 Reduced 1.84%	14,861 $210,000
Q3 2021 Oct 29, 2021	SELL	$10.18 - $26.64 $7,797 - $20,406	-766 Reduced 4.82%	15,140 $155,000
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $84,976 - $163,271	4,576 Added 40.39%	15,906 $424,000
Q1 2021 May 13, 2021	SELL	$31.0 - $55.72 $31,062 - $55,831	-1,002 Reduced 8.13%	11,330 $393,000
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $2,410 - $3,183	65 Added 0.53%	12,332 $457,000
Q3 2020 Oct 30, 2020	SELL	$40.47 - $45.5 $6,556 - $7,371	-162 Reduced 1.3%	12,267 $504,000
Q2 2020 Aug 10, 2020	SELL	$32.57 - $42.83 $46,868 - $61,632	-1,439 Reduced 10.38%	12,429 $504,000
Q1 2020 May 13, 2020	SELL	$23.3 - $45.96 $11,067 - $21,831	-475 Reduced 3.31%	13,868 $482,000
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $28,148 - $39,120	814 Added 6.02%	14,343 $615,000
Q3 2019 Nov 13, 2019	SELL	$36.98 - $48.45 $6,212 - $8,139	-168 Reduced 1.23%	13,529 $500,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $79,709 - $125,997	2,269 Added 19.85%	13,697 $619,000
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $19,958 - $27,918	466 Added 4.25%	11,428 $621,000
Q4 2018 Feb 15, 2019	BUY	$37.97 - $60.16 $250,146 - $396,334	6,588 Added 150.62%	10,962 $507,000
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $396,408 - $473,507	-7,041 Reduced 61.68%	4,374 $266,000
Q2 2018 Jul 18, 2018	BUY	$44.9 - $64.95 $95,008 - $137,434	2,116 Added 22.76%	11,415 $715,000
Q1 2018 May 22, 2018	SELL	$45.35 - $61.65 $8,616 - $11,713	-190 Reduced 2.0%	9,299 $430,000
Q4 2017 Feb 13, 2018	BUY	$41.95 - $60.1 $44,718 - $64,066	1,066 Added 12.66%	9,489 $450,000
Q3 2017 Nov 09, 2017	BUY	$33.4 - $53.9 $281,328 - $453,999	8,423	8,423 $453,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account